机构地区:[1]宁德师范学院附属宁德市医院血液科,宁德352100
出 处:《国际医药卫生导报》2023年第13期1808-1812,共5页International Medicine and Health Guidance News
基 金:福建省自然科学基金面上项目(2020J011346)。
摘 要:目的探讨Mcl-1基因异常表达在阵发性睡眠性血红蛋白尿症(PNH)异常克隆中的抗凋亡作用。方法选取2020年2月至2022年2月在宁德师范学院附属宁德市医院血液科就诊的13例PNH患者为病例组(男7例,女6例,中位年龄27岁),15例健康体检者为对照组(男8例,女7例,中位年龄38岁)。实时荧光定量多聚核苷酸链式反应(RT-PCR)检测PNH异常克隆细胞与正常细胞中Mcl-1基因mRNA的表达水平,然后敲除PNH患者CD59^(-)细胞中Mcl-1基因后检测siRNA-Mcl-1转染前后PNH异常克隆细胞的增殖、凋亡及细胞周期分布等生物学变化。统计学方法采用Fisher确切概率法、独立样本t检验、秩和检验。结果PNH患者CD59^(-)细胞组、CD59^(+)细胞组、对照组的Mcl-1基因mRNA的表达量分别为(2.48±0.25)、(1.61±0.19)、(1.21±0.08),CD59^(-)细胞组高于CD59^(+)细胞组及对照组(P=0.031、0.022),而CD59^(+)细胞组和对照组间比较差异无统计学意义(P=0.126)。同时PNH患者Mcl-1基因mRNA的相对表达量与CD59^(-)克隆细胞数呈正相关(r^(2)=0.523,P=0.012)。PNH患者CD59^(-)细胞转染靶向siRNA-Mcl-1后,Mcl-1 mRNA表达水平明显下降。siRNA-Mcl-1转染组细胞凋亡率高于转染无义序列组(siRNA-scr转染组)和空白对照组[(43.12±16.33)%比(24.07±15.42)%、(21.56±14.85)%],差异均有统计学意义(均P<0.05)。siRNA-Mcl-1转染组G_(0)/G_(1)期细胞比例高于siRNA-scr转染组和空白对照组[(93.16±3.06)%比(91.52±4.01)%、(90.78±3.62)%],而S期细胞比例低于siRNA-scr转染组和空白对照组[(4.96±3.21)%比(6.86±3.87)%、(7.05±3.59)%],差异均有统计学意义(均P<0.05)。结论siRNA-Mcl-1转染能减弱PNH患者CD59^(-)细胞的增殖,促进凋亡。Mcl-1基因的过表达可能在PNH克隆抗凋亡中起作用。Objective To investigate the anti-apoptotic effect of abnormal Mcl-1 expression in clones of paroxysmal nocturnal hemoglobinuria(PNH).Methods Thirteen PNH patients admitted to Department of Hematology,Ningde Municipal Hospital of Ningde Normal University from February 2020 to February 2022 were selected as a case group(7 males and 6 females,with a median age of 27 years old),and fifteen healthy subjects were selected as a control group(8 males and 7 females,with a median age of 38 years old).The expressions of Mcl-1 mRNA in abnormal PNH cloned cells and normal cells were detected by real-time quantitative polymerase chain reaction(RT-PCR),and then the proliferation,apoptosis,and cell cycle distribution of abnormal PNH cloned cells were detected before and after transfection of siRNA-Mcl-1.Fisher exact probability method,independent-sample t test,and rank sum test were used.Results The expressions of Mcl-1 mRNA in the CD59^(-)cells,the CD59^(+)cells,and the control group were(2.48±0.25),(1.61±0.19),and(1.21±0.08),respectively,that in the CD59^(-)cells was significantly higher than those in the CD59^(+)cells and the control group(P=0.031 and 0.022),but there was no statistically significant difference between the CD59^(+)cells and the control group(P=0.126).The relative expression of Mcl-1 mRNA in the PNH patients was positively correlated with the number of CD59^(-)clone cells(r^(2)=0.523,P=0.012).After Mcl-1 gene silence by siRNA,the Mcl-1 mRNA expression was decreased significantly.The apoptosis rate of the siRNA-Mcl-1 transfection group was significantly higher than those of the siRNA-scr transfection group and the blank control group[(43.12±16.33)%vs.(24.07±15.42)%and(21.56±14.85)%],with statistically significant differences(both P<0.05).The proportion of G_(0)/G_(1) phase cells in the siRNA-Mcl-1 transfection group was higher than those in the siRNA-scr transfection group and the blank control group[(93.16±3.06)%vs.(91.52±4.01)%and(90.78±3.62)%],and the proportion of S-phase cells was lower than thos
关 键 词:阵发性睡眠性血红蛋白尿症 CD59^(-) CD59^(+) MCL-1 抗凋亡
分 类 号:R55[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...